Tekla Capital Management LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+47,873
(5.0%)
New positions
8
Sold out positions
5
Turnover %
6.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MYLAN INC | 10,659 | 50.3% |
| BMRN | 10,596 | 58.4% |
| CELLADON CORP | 9,833 | NEW |
| HRTX | 9,690 | NEW |
| Endo International plc | 8,665 | NEW |
| AMGN | 8,397 | 17.8% |
| OVERSEAS SHIPHOLDING GROUP INC | 8,344 | 45.1% |
| ACTAVIS INC | 7,786 | 22.5% |
| QUESTCOR PHARMACEUTICALS INC COM | 7,602 | NEW |
| RVTY | 6,373 | 587.9% |
Top Reduces (Value $000, Stocks/ETFs)
| CELG | -20,279 | -23.5% |
| HOLX | -9,939 | -100.0% |
| ENDO PHARMACEUTICALS HLDGS | -8,514 | -100.0% |
| REGN | -8,346 | -11.6% |
| PRGO | -7,971 | -23.5% |
| AKORN INC | -7,662 | -33.2% |
| IBB | -6,767 | -21.9% |
| GILD | -6,455 | -5.7% |
| PHARMACYCLICS INC | -4,841 | -46.7% |
| CVS | -3,843 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|